Bioimpacts. 2016;6(3): 169-181. doi: 10.15171/bi.2016.23
PMID: 27853680        PMCID: PMC5108989


Radiolabeled theranostics: magnetic and gold nanoparticles

Cited by CrossRef: 30

1- Zamanlu M, Farhoudi M, Eskandani M, Mahmoudi J, Barar J, Rafi M, Omidi Y. Recent advances in targeted delivery of tissue plasminogen activator for enhanced thrombolysis in ischaemic stroke. Journal of Drug Targeting. 2018;26(2):95 [Crossref]
2- Asgharzadeh M, Barar J, Pourseif M, Eskandani M, Jafari Niya M, Mashayekhi M, Omidi Y. Molecular machineries of pH dysregulation in tumor microenvironment: potential targets for cancer therapy. Bioimpacts. 2017;7(2):115 [Crossref]
3- Zhang Y, Zhang Y, Yin L, Xia X, Hu F, Liu Q, Qin C, Lan X. Synthesis and Bioevaluation of Iodine-131 Directly Labeled Cyclic RGD-PEGylated Gold Nanorods for Tumor-Targeted Imaging. Contrast Media & Molecular Imaging. 2017;2017:1 [Crossref]
4- Millart E, Lesieur S, Faivre V. Superparamagnetic lipid-based hybrid nanosystems for drug delivery. Expert Opinion on Drug Delivery. 2018;15(5):523 [Crossref]
5- Fakhari A, Aghanejad A, Jalilian A, Gharepapagh E. Recent developments in targeted imaging of CXCR4-chemokine receptor. J Radioanal Nucl Chem. 2018;317(1):1 [Crossref]
6- Fathi F, Rashidi M, Omidi Y. Ultra-sensitive detection by metal nanoparticles-mediated enhanced SPR biosensors. Talanta. 2019;192:118 [Crossref]
7- Drude N, Tienken L, Mottaghy F. Theranostic and nanotheranostic probes in nuclear medicine. Methods. 2017;130:14 [Crossref]
8- Safary A, Akbarzadeh Khiavi M, Mousavi R, Barar J, Rafi M. Enzyme replacement therapies: what is the best option?. Bioimpacts. 2018;8(3):153 [Crossref]
9- Saha Ray A, Ghann W, Tsoi P, Szychowski B, Dockery L, Pak Y, Li W, Kane M, Swaan P, Daniel M. Set of Highly Stable Amine- and Carboxylate-Terminated Dendronized Au Nanoparticles with Dense Coating and Nontoxic Mixed-Dendronized Form. Langmuir. 2019;35(9):3391 [Crossref]
10- Stafford S, Serrano Garcia R, Gun’ko Y. Multimodal Magnetic-Plasmonic Nanoparticles for Biomedical Applications. Applied Sciences. 2018;8(1):97 [Crossref]
11- Xu X, Bayazitoglu Y, Meade A. Evaluation of theranostic perspective of gold-silica nanoshell for cancer nano-medicine: a numerical parametric study. Lasers Med Sci. 2019;34(2):377 [Crossref]
12- Fathi M, Majidi S, Zangabad P, Barar J, Erfan-Niya H, Omidi Y. Chitosan-based multifunctional nanomedicines and theranostics for targeted therapy of cancer. Med Res Rev. 2018;38(6):2110 [Crossref]
13- Aghanejad A, Babamiri H, Adibkia K, Barar J, Omidi Y. Mucin-1 aptamer-armed superparamagnetic iron oxide nanoparticles for targeted delivery of doxorubicin to breast cancer cells. BI. 2018;8(2):117 [Crossref]
14- Shetty Y, Prabhu P, Prabhakar B. Emerging vistas in theranostic medicine. International Journal of Pharmaceutics. 2019;558:29 [Crossref]
15- Chakravarty R, Chakraborty S, Guleria A, Shukla R, Kumar C, Vimalnath Nair K, Sarma H, Tyagi A, Dash A. Facile One-Pot Synthesis of Intrinsically Radiolabeled and Cyclic RGD Conjugated 199Au Nanoparticles for Potential Use in Nanoscale Brachytherapy. Ind Eng Chem Res. 2018;57(43):14337 [Crossref]
16- Sztandera K, Gorzkiewicz M, Klajnert-Maculewicz B. Gold Nanoparticles in Cancer Treatment. Mol Pharmaceutics. 2019;16(1):1 [Crossref]
17- Lin L, Starostin S, Li S, Hessel V. Synthesis of metallic nanoparticles by microplasma. 2018;3(10) [Crossref]
18- Nedyalkova M, Donkova B, Romanova J, Tzvetkov G, Madurga S, Simeonov V. Iron oxide nanoparticles – In vivo/in vitro biomedical applications and in silico studies. Advances in Colloid and Interface Science. 2017;249:192 [Crossref]
19- Vandghanooni S, Eskandani M, Barar J, Omidi Y. Recent advances in aptamer-armed multimodal theranostic nanosystems for imaging and targeted therapy of cancer. European Journal of Pharmaceutical Sciences. 2018;117:301 [Crossref]
20- Shams S, Ghazanfari M, Schmitz-Antoniak C. Magnetic-Plasmonic Heterodimer Nanoparticles: Designing Contemporarily Features for Emerging Biomedical Diagnosis and Treatments. Nanomaterials. 2019;9(1):97 [Crossref]
21- Ranjbar-Navazi Z, Eskandani M, Johari-Ahar M, Nemati A, Akbari H, Davaran S, Omidi Y. Doxorubicin-conjugated D-glucosamine- and folate- bi-functionalised InP/ZnS quantum dots for cancer cells imaging and therapy. Journal of Drug Targeting. 2018;26(3):267 [Crossref]
22- Borran A, Aghanejad A, Farajollahi A, Barar J, Omidi Y. Gold nanoparticles for radiosensitizing and imaging of cancer cells. Radiation Physics and Chemistry. 2018;152:137 [Crossref]
23- Dai G, Wan W, Chen J, Wu J, Shuai X, Wang Y. Enhanced osteogenic differentiation of MC3T3-E1 on rhBMP-2 immobilized titanium surface through polymer-mediated electrostatic interaction. Applied Surface Science. 2019;471:986 [Crossref]
24- Tong J, Hou X, Liu S, Zhang J, Ding Y, Wang Y, Xu H, Liu B. One-Step Synthesis of Dicyanobenzene-Derived Nitrogen-Doped Porous Carbon Monolayers: Porosity and Near-infrared Photoactivity. ChemCatChem. 2017;9(21):4043 [Crossref]

BioImpacts, as a peer-reviewed international journal, publishes all types of papers on bench-to-bedside translational aspects of pharmaceutical and biomedical sciences. As a "Publish Free" and "Access Free" journal, BioImpacts follows a constructive peer-review process with free editing service to benefit the scientific community worldwide.